Dipyridamole 100mg tablets

国: イギリス

言語: 英語

ソース: MHRA (Medicines & Healthcare Products Regulatory Agency)

有効成分:

Dipyridamole

から入手可能:

Viatris UK Healthcare Ltd

ATCコード:

B01AC07

INN（国際名）:

Dipyridamole

投薬量:

100mg

医薬品形態:

Oral tablet

投与経路:

Oral

クラス:

No Controlled Drug Status

処方タイプ:

Valid as a prescribable product

製品概要:

BNF: 02090000; GTIN: 5016695300375

情報リーフレット

PERSANTIN 100MG TABLETS
(dipyridamole)
PATIENT INFORMATION LEAFLET
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE
*
Keep this leaflet. You may need to read it again.
*
If you have any further questions, ask your doctor or pharmacist
*
This medicine has been prescribed for you. Do not pass it on to
others. It
may harm them, even if their symptoms are the same as yours.
*
If any of the side effects gets troublesome or serious, or if you
notice any
side effects not listed in this leaflet, please tell your doctor or
pharmacist.
Your medicine is called Persantin 100mg Tablets, but will be reffered
to as
Persantin Tablets throughout this leaflet.
IN THIS LEAFLET:
What Persantin Tablets are and what they are used for
Before you take Persantin Tablets
How to take Persantin Tablets
Possible side effects
How to store Persantin Tablets
Further information
WHAT PERSANTIN TABLETS ARE AND WHAT THEY ARE USED
FOR
The name of your medicine is Persantin Tablets. It contains a medicine
called Dipyridamole. This belongs to a group of medicines called
‘anti-thrombotic agents’, which are used to help stop blood clots
forming.
Persantin Tablets help stop blood clots which may occur if you have
had
your heart valves replaced.
BEFORE YOU TAKE PERSANTIN TABLETS
DO NOT TAKE PERSANTIN TABLETS IF YOU ARE ALLERGIC (HYPERSENSITIVE) TO:
*
Dipyridamole
Any of the other ingredients of Persantin Tablets (see section 6:
Further
information)
TAKE SPECIAL CARE WITH PERSANTIN TABLETS
Check with your doctor or pharmacist before taking your medicine if:
*
You have angina or other heart problems (including heart valve or
circulation problems) or have had a recent heart attack
*
You have myasthenia gravis (a rare muscle problem)
*
You have any bleeding problems
*
You are pregnant or planning to become pregnant or are breast-feeding
*
You have been told by your doctor that you have an intolerance to some
sugars
If you are not sure if any of the above apply to you, talk to your
doctor or
pharmacist before taking Persantin Table

製品の特徴

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Dipyridamole Tablets 100mg
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Dipyridamole 100 mg
Also contains 96.0 mg of lactose and 107.20 mg of sucrose. For the
full list of
excipients, see section 6.1.
3
PHARMACEUTICAL FORM
Sugar-coated tablet
White biconvex sugar-coated tablets with 9.5 mm in diameter
approximately and
plain on both sides.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
As an adjunct to oral anti-coagulation for prophylaxis of
thromboembolism
associated with prosthetic heart valves.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Posology
Adults:
300-600 mg daily in three or four doses.
Paediatric population:
Dipyridamole is not recommended for children.
Elderly:
As for adults.
METHOD OF ADMINISTRATION
Dipyridamole is taken by mouth, and should usually be taken before
meals.
4.3
CONTRAINDICATIONS
Hypersensitivity to the active substance or to any of the excipients
listed in section
6.1. Patients with known cardiac conduction difficulties or
dysrhythmias.
4.4
SPECIAL WARNINGS AND PRECAUTIONS FOR USE
Dipyridamole is a potent vasodilator and should be used with caution
in patients
with rapidly worsening angina, sub-valvular aortic stenosis or
haemodynamic
instability (e.g. decompensated heart failure) associated with a
recently sustained
myocardial infarction.
Patients being treated with regular oral doses of Dipyridamole should
not receive
additional intravenous Dipyridamole. Clinical experience suggests that
patients
being treated with oral dipyridamole who also required pharmacological
stress
testing with intravenous dipyridamole, should discontinue drugs
containing oral
dipyridamole for twenty-four hours prior to stress testing.
Dipyridamole should be used with caution in patients with coagulation
disorders.
In patients with myasthenia gravis, readjustment of therapy may be
necessary
after changes in dipyridamole dosage (see Drug Interactions).
A small number of cases have been reported in which unconjugated
dipyridamole
was shown to